KUULEIKUPONOOKEALOHA NAAHIELUA: Open Payments
NPI 1467826925 · AIEA, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,745 in 141 payments from 16 companies in 2025. Trend: 2023 $968 · 2024 $1,420 · 2025 $3,745
Food & beverage: $3,580Education: $165
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $930 |
| Teva Pharmaceuticals USA, Inc. | 16 | $542 |
| Otsuka America Pharmaceutical, Inc. | 18 | $383 |
| Novo Nordisk Inc | 18 | $361 |
| E.R. Squibb & Sons, L.L.C. | 11 | $259 |
| Mannkind Corporation | 9 | $246 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $188 |
| Xeris Pharmaceuticals, Inc. | 9 | $187 |
| Alkermes, Inc. | 12 | $184 |
| Janssen Pharmaceuticals, Inc | 5 | $168 |
Products named: VRAYLAR, AUSTEDO XR, COBENFY, AFREZZA, ABILIFY MAINTENA, Wegovy, CAPLYTA, RECORLEV.
Industry payments across HI — which companies pay providers there.
